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The application of nanomaterials in the ﬁelds of medicine and biotechnology is of enormous interest, particularly in the areas where
traditional solutions have failed. Unfortunately, there is very little information on how to optimize the preparation of nanomaterials
for their use in cell culture and on the eﬀects that these can trigger on standard cellular systems. These data are pivotal in
nanobiotechnology for the development of diﬀerent applications and to evaluate/compare the cytotoxicity among the diﬀerent
nanomaterials or studies. The lack of information drives many laboratories to waste resources performing redundant
comparative tests that often lead to partial answers due to diﬀerences in (i) the nature of the start-up material, (ii) the
preparation, (iii) functionalization, (iv) resuspension, (v) the stability/dose of the nanomaterial, etc. These variations in addition
to the diﬀerent analytical systems contribute to the artefactual interpretation of the eﬀects of nanomaterials and to inconsistent
conclusions between diﬀerent laboratories. Here, we present a brief review of a wide range of nanomaterials (nanotubes, various
nanoparticles, graphene oxide, and liposomes) with HeLa cells as a reference cellular system. These human cells, widely used as
cellular models for many studies, represent a reference system for comparative studies between diﬀerent nanomaterials or
conditions and, in the last term, between diﬀerent laboratories.1. Introduction
Nanomaterials oﬀer revolutionary solutions to traditional
problems, and thus, they have been incorporated into many
diﬀerent consumer goods including many for human con-
sumption such as cosmetics, biotechnological and pharmaco-
logical products, medicines, or food additives. Unfortunately,
major developments are never exempt of associated problems.
Nanomaterials have been connected with all types of toxico-
logical, cumulative, or environmental problems [1–6]. How-
ever, the reality is that during evolution, vegetable and
animal species have been exposed to environmentally gener-
ated nanomaterials, and this has resulted in the appearance
of natural resistances. The issue to be faced now is tounderstand and control the eﬀect of the many diﬀerent
anthropogenic nanomaterials currently in use. Society needs
to know the implications of the use of the diﬀerent nanoma-
terials in everyday products. But to ﬁnd out the possible side
eﬀects of the exposure for each nanomaterial, it is necessary
to establish a series of in vitro and in vivo objective tests.
Cellular models are very convenient because they do not
require complex laboratory facilities and can provide pivotal
information on the toxicological eﬀects of nanomaterials;
furthermore, nowadays, there are many cellular models to
investigate these interactions with nanomaterials. In fact,
many studies have been carried out using cells of diﬀerent
origins and diverse natures. However, this poorly protoco-
lised research has resulted in the production of confusing
2 Journal of Nanomaterialsand incoherent data that result in chaos when it comes to
understanding and comparing the eﬀect of a particular nano-
material at the same dose in a unique cellular system.
In our laboratories, we have been studying the in vitro
eﬀects of several types of nanomaterials for almost a decade.
This has oﬀered us a broad critical view on the eﬀects pro-
duced by many of these compounds in diﬀerent cellular sys-
tems. We now know that the same nanomaterial can produce
diﬀerent cytotoxic eﬀects in diﬀerent cells, depending on the
nature and origin of the cell [7]. For example, macrophages
generally suﬀer more cumulative or degradative eﬀects-i.e.,
reactive oxygen species (ROS) accumulation-than other cells
for the same material at the same dose due to their high
avidity for capturing nanomaterials [8–13]. On the con-
trary, malignant melanoma or glioblastoma multiforme cells
have great resistance to cytotoxicity for most nanomaterials
[7, 14, 15]. Also, some cells have a special idiosyncrasy that
makes them tolerant to certain types of nanomaterials, such
as neurons. These cells can survive multiwalled carbon nano-
tube exposure better than macrophages but are much more
sensitive to any other nanomaterials [8, 16–18].
There are many examples in the literature where cells
exposed to the same nanomaterial respond diﬀerently. This
is the case of carbon nanotubes where the reported eﬀects
range from innocuity to very acute toxicological or long-
term accumulative eﬀects [19–24]. Moreover, in the case of
carbon nanotubes, there are diﬀerent cellular phenotypes,
after exposure, depending on the type of the used nanotubes.
For example, single-walled carbon nanotubes (SWCNTs)
seem to interact more with DNA [18, 25, 26] than multi-
walled carbon nanotubes (MWCNTs) that display biomi-
metic properties with the cytoskeleton [9, 15, 19, 27]. This
fact reveals the unique features of each nanomaterial, for
example in this case, carbon nanotubes, the importance of
the diameter of the tube in the interaction with diﬀerent bio-
logical ﬁlaments such as DNA (2nm), intermediate ﬁlaments
(10-15 nm), microtubules (25 nm), or actin (4-8 nm).
For all these reasons, it seems necessary to carry out stan-
dard tests where a single cell type is exposed to the same con-
centration of diﬀerent nanomaterials, functionalized, and
processed identically, following the same protocol. This test
allows the direct comparison of the eﬀect of the diﬀerent
nanomaterials on a unique system in vitro. For this study,
we have chosen HeLa cells as a reference cellular system. This
is a human epithelial cell line originally obtained from a cer-
vical carcinoma that is universally employed as a reference
cellular model to test numerous toxic products, among them,
nanomaterials. One of the great advantages of using this cell
line is that its genome and proteome are known in great
detail [28–30], and there are numerous studies performed
in many laboratories that provide extraordinary experimen-
tal support for these analyses.
On the other hand, this cell line has been used in many
laboratories on the assumption that it comprises putatively
homogeneous clonal cell population. However, recent studies
demonstrate that HeLa cells are heterogeneous [31]. This fact
means that the results between diﬀerent laboratories are not
always directly comparable or reproducible, reinforcing the
idea that a standard protocol must be carried out in the samecell line-from the same laboratory-to test diﬀerent nanoma-
terials processed in identical conditions. In this study, we
investigate the eﬀect of identically prepared (functionaliza-
tion/dose) nanomaterials. These were incubated for equal
periods of time and were analysed following the same proto-
col for direct comparison of their eﬀect on these cells, thus to
establish a comparison of their exposure phenotypes on this
unique cell model.
2. Materials and Methods
2.1. Nanomaterials.Diﬀerent nanomaterials were used in this
work. High-purity MWCNTs were obtained from Nanocyl
NC3100™. These nanotubes have been fully characterized
in previous publications [15]. Monodisperse silica spheres
(500 nm) were prepared using the Stöber method as
described in our previous work [32]. These silica particles
were coated with carbon nanotubes as detailed elsewhere
[33]. Cationic liposomes (CLPs) were commercially obtained
from Nanovex Biotechnologies SL and prepared from basic
components by a hydration process. All liposomes showed
a narrow size distribution with mean particle sizes of 150-
200 nm and polydispersity indexes of less than 0.4. TiO2
and ZnO nanoparticles (Z-COTE®) were commercial (BASF
Chemical Company). ZnO:Co2+ nanowires were synthesised
in-house [34–36]. Chemically exfoliated graphene oxide
(GO) was purchased commercially (Graphenea, Spain).
Morphological characterization of the nanomaterials was
performed using a JEOL JEM 1011 transmission electron
microscope (TEM) operating at 100 kV. Nanomaterials were
suspended in ethanol and adsorbed onto 400 mesh carbon-
coated copper grids.
2.2. Functionalization of Nanomaterials. Nanomaterials were
resuspended and functionalized in a saline solution contain-
ing 30% fetal bovine serum (FBS, Gibco) by mild probe
sonication (3-5 cycles, 2-5″ at a frequency of 20 kHz) in a
SONICS Vibra-Cell VCX130 Ultrasonic Processor (Sonics
&Materials Inc.), before resuspension in cell culture medium
and addition to the cell cultures.
2.3. Cell Culture, Cycle and Viability Tests, Staining,
Immunoﬂuorescence, and Imaging. HeLa cells (from the
European Molecular Biology Laboratory Cell Bank, passage
10) were cultured under standard conditions in Minimum
Essential Medium (MEM) containing 10% FBS and antibi-
otics (Gibco, Thermo Fisher Scientiﬁc). Phase contrast
micrographs were taken at diﬀerent time points using a
Progress CT5 (Jenoptik) digital camera coupled to a Nikon
Eclipse TS100-F. Cell viability assessments were performed
using a standard trypan blue assay. The cell cycle distribu-
tion was analysed by ﬂow cytometry using a Muse® Cell
Analyzer (Merck KGaA) following the manufacturer’s
instructions. Immunostaining was performed on cells ﬁxed
in 4% paraformaldehyde. Phalloidin-tetramethylrhodamine
B isothiocyanate, Hoechst dye (bisbenzimide), and Acridine
Orange hemi (zinc chloride) salt (all from Sigma-Aldrich)
were used to stain actin, DNA, and cytoplasm, respec-
tively. Microtubules were immunostained with the B512
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Figure 1: Multiwalled carbon nanotube (MWCNT) interaction with HeLa cells. (a) Diagram of their internalization and endo-lysosomal
escape. (b) Low- and high-resolution TEM images of MWCNTs. (c) Phase contrast images of the control and 72 h MWCNT-exposed
HeLa cells. (d) Asymmetric triple mitosis representative of the biomechanical defects triggered by MWCNTs in the microtubule
cytoskeletal machinery. (e) MWCNTs treatment resulted in a drop in the number of cells at the G1 stage (nondividing cells, represented
in light blue) and a rise of cells at S (DNA synthesis), G2 stage (mitotic), polyploidy (P, aberrant genomic load), and apoptosis. Changes in
the cell cycle after 72 h incubation with MWCNTs are indicative of cell cycle blockage.
3Journal of Nanomaterialsanti-α-tubulin antibody (Sigma-Aldrich) and a secondary
goat anti-mouse IgG antibody conjugated with Alexa
Fluor 488 (Molecular Probes, Invitrogen). Confocal micros-
copy images were performed with a Nikon A1R confocal
microscope and were processed with the NIS-Elements
Advanced Research software. All confocal cell images are
pseudocoloured.
3. Results and Discussion
3.1. Carbon Nanotubes. Carbon nanotubes (CNTs) repre-
sent a class of highly versatile materials that display very
interesting mechanical, thermal, electronic, and biological
properties [37]. These nanomaterials have been broadly
used in numerous in vitro and in vivo toxicity studies,
and there is a lot of documentation regarding their eﬀects.
However, there is some confusion in the literature that we
think could be due to the purity, the surface treatment, or
the morphological properties of the nanotubes, among
others. Here, we investigate the eﬀect of MWCNTs on HeLa
cells incubated with 50μg/ml. Figure 1(b) shows the charac-
terization of these nanomaterials by TEM and the diﬀerent
steps of the internalization in these cells. For their use,
MWCNTs are functionalized with serum proteins to trigger
receptor-mediated endocytosis (Figure 1(a)) [38–40].Figure 1(c) (B) shows HeLa cells incubated with 50μg/ml
of MWCNTs for 72h. Previous studies report how
MWCNTs have a high aﬃnity for the cellular cytoskeleton
[9, 21, 41], causing detectable morphological changes and
alterations in the biomechanics of HeLa cells which
results in slower migration rates [15, 19], proliferative
blockage, and, depending on the dose/exposure time,
genomic instability and cytotoxic eﬀects (Figure 1(d)) [7,
42–44]. In this study, HeLa cells exposed to nanotubes
display an elongated morphology (Figure 1(c)), abnormal
mitotic ﬁgures (Figure 1(d)), and aberrant cell cycles
(Figure 1(e)) where we can see an increased S and/or
G2 phases, depending on the incubation dose/times. Con-
focal microscopy examination of MWCNT-treated cell
cultures conﬁrmed indicative signs of the biomechanical
and disruptive eﬀects of these nanotubes on HeLa cells,
including (i) cell retraction, (ii) membrane blebbing, (iii)
nuclear DNA compaction, and (iv) the presence of micronu-
clei, as well as other previously described cytoskeletal
changes including disorganized microtubular patterns or
a reactive cortical actin [14]. These morphological changes
and cytotoxic eﬀects were corroborated by ﬂow cytometry
(Figure 1(e)), showing a patent blockage in the S phase
of the cell cycle, suggesting MWCNT interference with
DNA replication.
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Figure 2: Silica particle interaction with HeLa cells. (a) Schematic diagram of silica particles processing in HeLa cells. Particles are
internalized in cells via endocytosis. In endo-lysosomes, their biocorona is degraded, and stripped particles are ﬁnally exocytosed. ((b), A)
TEM characterization of the as-prepared silica particles. ((b), B) Confocal image demonstrating silica particles inside HeLa cells. (c)
Confocal image where the exocytosed silica particles are detected (red arrows). The accompanying histogram shows the percentage of
extracellular particles after 15′, 30′, 1 h, 2 h, and overnight. ((d), A) Percentage of live cells at diﬀerent exposure times. ((d), B) Phase
contrast image of HeLa cells presenting no detectable cytotoxicity.
4 Journal of Nanomaterials3.2. Silica Particles. Silica particles are traditionally consid-
ered to be quite biocompatible and have been used as a ther-
apy delivery system due to their interesting physico-chemical
properties [45]. Figure 2 compilates the characteristics of
these particles and several aspects of their relationship with
the HeLa cells used in this study. These particles of ca.
500 nm diameter size, when functionalized with serum pro-
teins, are receptor-mediated endocytosed. Figure 2(b) (B)
shows the trajectory of these particles inside HeLa cells:
particles are rapidly internalized by HeLa cells after over-
night exposure. In the endo-lysosomal route, the silica
particle biocorona proteins are degraded by the local lyso-
somal proteases. Protein-stripped silica particles are exocy-
tosed from these cells a few hours after engulfment (see
Figure 2(c)) [33]. These exocytosed silica particles can be
reendocytosed after adsorbing other proteins from the sur-
rounding culture medium on their surfaces as part of the
biocorona. Previous studies demonstrate a constant con-
centration of approximately 30% of the total particles in
the culture outside the cells [32]. As shown in Figure 2(d),silica particles are highly biocompatible at 50μg/ml, and no
signiﬁcant changes in the morphology of the cells after 72 h
of exposure were appreciated.3.3. CNT-Coated Silica Particles. Carbon nanotubes can be
used to coat silica particles to trigger the lysosomal exit
imitating viral escape mechanisms [33, 46]. Figure 3 shows
a summary of the results obtained after the exposure of
HeLa cells to silica particles coated with MWCNTs. Since
the carbon nanotubes of the coating are functionalized
with serum proteins, nanotube-coated silica particles also
enter cells via endocytosis (Figure 3(c), A). Once inside
the endo-lysosome, the local proteases degrade the coating
proteins, stripping the carbon nanotubes that then interact
with the lysosomal membrane (Figure 3(c), B), tearing the
vesicle apart and escaping into the cytosol [33]. These
CNT-coated silica particles do not trigger detectable cyto-
toxicity either (Figure 3(d)) at a ﬁnal concentration of
50μg/ml [33, 46].
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Figure 3: CNT-silica particle interaction with HeLa cells. (a) Schematic diagram of CNT-silica particle trajectory in HeLa cells. Once these
particles are internalized via endocytosis, the CNT biocorona is degraded. Stripped nanotubes interact with the lysosomal membrane and
escape the endo-lysosomal compartment. (b) TEM images of some representative CNT-silica particles. ((c), A) Confocal microscopy
images demonstrating internalized particles in HeLa cells (red arrows). ((c), B) TEM micrograph of a section of a HeLa cell cytoplasm
where the CNTs of the coating are observed piercing the endo-lysosomal membrane. ((d), A) Percentage of live cells after 24 h, 48 h, and 72 h
of exposure to 50μg/ml of the CNT-coated particles. ((d), B) Phase contrast image of HeLa cells displaying no detectable cytotoxic changes.
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Figure 4: GO interaction with HeLa cells. (a) Schematic diagram of functionalized GO contacting with cellular surface receptors and invading
the cell via endocytosis. Internalized GO ﬂakes are progressively degraded in lysosomes. (b) TEM characterization of GO ﬂakes. (c) Confocal
microscopy image of HeLa cells exposed to 50μg/ml functionalized GO ﬂakes displaying a normal morphology after 72 h exposure.
5Journal of Nanomaterials
3Cationic liposomes
Endocytosis
Endo-lysosome
Degradation and
endo-lysosomal
escape
Vesicles
(a)
Cy
to
pl
as
m
/n
uc
le
i/l
ip
os
om
es
(b) (c)
100
75
50
25
0
Cell survival
Control Cationic
liposomes
24 h
48 h
72 h
(d) (e)
G1 (%)
G2 (%)
S (%)
Control
Cationic
liposomes
(f)
Figure 5: Cationic liposome interaction with HeLa cells. (a) Graphic illustration of the intracellular cycle of cationic liposomes in HeLa cells.
(b) Confocal microscopy image of HeLa cells exposed to DiI-labelled cationic liposomes (red channel, in boxes). (c) TEM image of the as-
prepared cationic liposomes. (d) HeLa cell viability after cationic liposome exposure. (e) Phase contrast image of HeLa cells exposed to the
cationic liposomes for 72 h. (f) Comparative study of the cell cycle between HeLa cells with CLP by ﬂow cytometry.
6 Journal of Nanomaterials3.4. Graphene Oxide (GO) Flakes. Graphene oxide is a nano-
material that, up to date, has been reported to be quite bio-
compatible in diﬀerent systems in vitro and in vivo. The
GO composition, the ﬂat morphology, and the oxidation of
the structure result in a very biocompatible element. Oxi-
dised graphene allotropes have been shown to be degradable
by lysosomal enzymes, being much more biocompatible than
the nonoxidised counterpart nanostructures [47–50]. Oxida-
tion produces small enzymatic attack points on the graphene
layers that favour degradation by the lysosomal enzymes.
Figure 4 shows a summary of the intracellular entry and
trajectory of GO in HeLa cells. GO produces little detectable
morphological or biomechanical changes at the concentra-
tion of 50μg/ml. Figure 4(b) shows a TEM micrograph of
one of the GO sheets used in this study. As with carbon
nanotubes, GO is functionalized by serum proteins absorbed
on the surface. This protein corona triggers receptor-
mediated cellular entry. Unlike for carbon nanotubes, no
interaction phenomena of GO with intracellular ﬁlamentssuch as DNA, microtubules, or actin are observed or reported
so far (Figure 4(c)).
3.5. Liposomes. Liposomes are widely used as delivery sys-
tems to transfer drugs, proteins, or nucleic acids into target
cells. These nanovesicles made up of a lipid bilayer can
encapsulate diﬀerent types of therapies into an inner aqueous
phase or lipid bilayer and are considered, in general, very bio-
compatible nanostructures [51–53]. To improve the carrier
eﬃciency, it is necessary to understand the mechanism of
uptake into cells and the release of the therapy in the cyto-
plasm of the target cell, and both depend on the composition
of the lipocarrier. In our study, liposomes are functionalized
in 30% serum, just like the other nanomaterials. These partic-
ular types of commercial cationic liposomes (see Materials
and Methods) are captured by endocytosis, after interacting
with the cell surface receptors (Figure 5(a)). As a general rule,
this process is strongly inﬂuenced by the nature and den-
sity of the charge of the liposomes. Figure 5 depicts some
Functionalized TiO2 nanoparticles
Endocytosis
Degradation of
the biocorona
Vesicles
Cytoplasmic
accomulation
(a)
M
ic
ro
tu
bu
le
s/
nu
cle
i
(b) (c)
100
75
50
25
0
Control TiO2 NPs
24 h
48 h
72 h
Cell survival
(d)
50
 𝜇
g/
m
l T
iO
2 N
Ps
(e)
Figure 6: Titanium oxide nanoparticle interaction with HeLa cells. (a) Graphic illustration of the intracellular trajectory of TiO2
nanoparticles in HeLa cells. (b) Confocal microscopy images of HeLa cells exposed to TiO2 nanoparticles where no morphological
changes are observed. (c) TEM images of the pristine TiO2 nanoparticles. (d) Cell survival after exposure to 50μg/ml of TiO2
nanoparticles. (e) Phase contrast images of HeLa cells exposed to TiO2 nanoparticles during 24, 48, and 72 h.
7Journal of Nanomaterialscharacteristic data of these liposomes and their interaction
with HeLa cells. Cultures were incubated with the lipo-
somes resuspended in MEM medium for 72 h at 37°C.
Figure 5(b) (boxes) shows a few DiI-labelled cationic lipo-
somes inside HeLa cells. This particular type of liposomes
did not trigger any observable morphological changes in
HeLa cells. Neither changes were observed in the cell cycle
or viability of HeLa cells after 72 h incubation with these
nanomaterials (Figures 5(d) and 5(f)).
3.6. TiO2 Nanoparticles. Titanium dioxide (TiO2) nanopar-
ticles are some of the most commonly manufactured
nanomaterials that are extensively used as components of
paints, cosmetics, food, and many other consumer prod-
ucts [1, 54]. Due to their physical and chemical properties,
traditionally, TiO2 nanoparticles have been considered as a
low-toxicity; in fact, they are often used as negative con-
trols in several studies [55]. However, there are increasing
evidences in in vitro studies suggesting that they can
induce oxidative stress and genotoxicity upon UVA expo-
sure [56]. In our standard assay, HeLa cells exposed to
high doses (50μg/ml) of TiO2 nanoparticles display no
observable eﬀects [57]. Figure 6 shows a summary of the
ﬁndings in HeLa cells exposed to serum-functionalized
TiO2. Confocal microscopy images of HeLa cells show a
normal distribution of microtubules without any evidence
of alteration in cell morphology (Figure 6(b)). Neither
were there detected abnormalities in the cell cycle nor
increased cell death after exposure to these particles, visi-
ble in vesicles in the cellular cytoplasm 72h after exposure[57–60]. Furthermore, some TiO2 nanoparticle aggregates
were observed in the centrosomal region of the cells, as
previously reported [61]. Interestingly, these nanoparticles
can remain encapsulated in membranes for long periods
of time (24-48 h) without any evidence of their exocytosis
[60]. In general, most studies carried out in HeLa support
the hypothesis that TiO2 nanoparticles are highly biocom-
patible under standard culture conditions.
3.7. ZnO Nanoparticles and Nanowires. HeLa cells that are
subjected to treatment with ZnO display a very acute phe-
notype of cytotoxicity due to the dissolution of the ZnO
nanoparticles inside the lysosomes [57, 62–64]. Cells need
very small amounts of zinc, and that is why they have
exquisite membrane systems to control the entrance of
ﬁlms into the cytoplasm. When ZnO nanoparticles are
incubated in medium containing serum proteins, they
acquire a biocorona that the cell recognizes through its
membrane receptors triggering receptor-mediated endocy-
tosis. Once in the endosome, the pH of these vesicles
decrease and ZnO nanoparticles dissolve, releasing massive
amounts of zinc ions in the vesicle that invade the cell
cytoplasm. Within the cellular cytoplasm, there is a series
of proteins that captures zinc transiently functioning as
an intracellular buﬀering system (Figure 7(a)). Two of
these proteins are actin and tubulin. The microtubules,
built of nanotubes of tubulin units, are transformed into
sharp sheets of tubulin upon zinc incorporation in their
structure [57]. This causes the hardening and thickening
of the microtubules that behave like “daggers” perforating
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Figure 7: Interaction of ZnO nanoparticles and nanowires with HeLa cells. (a) Graphic illustration of the intracellular cycle of ZnO
nanomaterials in HeLa cells. (b) TEM characterization of ZnO nanoparticles (A) and nanowires (B). (c) Phase contrast images of HeLa
cells exposed to 50 μg/ml of ZnO nanoparticles (A) and nanowires (B) during 72 h. (d) Confocal microscopy images demonstrating the
cytotoxic eﬀects of ZnO nanoparticles (A) and nanowires (B) of HeLa cells. Cytoskeletal abnormalities are clearly visible. (e) HeLa cell
viability after ZnO nanoparticle exposure.
8 Journal of Nanomaterialsthe cell membrane causing immediate cell necrosis. This
eﬀect can be seen in the immunoﬂuorescence image from
Figure 7(d) (A).
ZnO:Co2+ nanowires caused very similar eﬀect to ZnO
nanoparticles despite the diﬀerent morphology and com-
position. These nanomaterials functionalized with serum
proteins interact with membrane receptors, trigger endocy-
tosis, and ﬁnally, dissolve in the lysosomes virtually identi-
cal to ZnO nanoparticles [57, 65]. As observed for the
ZnO nanoparticles, these nanowires produced changes in
the microtubule and actin cytoskeletons (Figure 7(a)), sta-
bilizing both cytoskeletal polymers and producing necrotic
changes derived from the perforation of the cell mem-
brane by the microtubules (Figure 7(d), B).4. Conclusions
Our work shows how the toxicological eﬀects of nanomater-
ials can result from the morphology of the nanomaterialsand/or their composition. In this review, we report several
cases that illustrate these behaviours. In the case of carbon
nanotubes and GO, it is the morphology rather than the com-
position factor that triggers the cytotoxic response in the
HeLa cells. However, this is not a universal dogma, for
ZnO-based nanomaterials, morphology is less important
than chemistry, and it is its composition and their chemical
properties which trigger the cytotoxic eﬀect in that case. Also,
this work demonstrates how nanomaterials can produce
unpredictable consequences in human HeLa cells; even if we
can know the composition andmorphology of nanomaterials,
a complete cytotoxic study should be performed in each case.
Our results show that although all employed nanomater-
ials interact with cells by receptor-mediated endocytosis, the
route that they follow once inside the cell is not the same. As
we can see, our study reinforces the idea that it is necessary to
develop speciﬁc tests for each nanomaterial, since it is not
possible to anticipate the cytotoxic eﬀects and/or the interac-
tion with cells and tissues.
49Journal of NanomaterialsThis exhaustive study constitutes an extraordinary tool
for the modelling of more complex structures, incorporating
materials endowed with magnetic, optical, or catalytic func-
tionalities. In fact, the carbon nanotubes provide a high sur-
face, which makes easier the adsorption of many diﬀerent
ligands, together with other porous or hollow materials like
mesoporous SiO2 or liposomes. Also, we can take advantage
of other materials that are innocuous to these cells like TiO2
in order to improve the biostability. This can increase the
applications of these nanomaterials as drug delivery systems,
therapy or diagnostic.
Nanomedicine and in particular the study of these
interactions between nanomaterials and biological systems
is a ﬁeld in constant development and evolution that
changes every day making the designs and the possibilities
almost endless.
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